<?xml version="1.0" encoding="UTF-8"?>
<author-notes>
 <fn fn-type="COI-statement" id="coi001">
  <p>
   <bold>Competing Interests: </bold>The NAIs oseltamivir carboxylate (oseltamivir) and zanamivir were provided by Hoffmann-La Roche, Ltd. (Basel, Switzerland). The NAI peramivir was provided by BioCryst Pharmaceuticals (Birmingham, AL). There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
  </p>
 </fn>
 <corresp id="cor001">* E-mail: 
  <email>elena.govorkova@stjude.org</email>
 </corresp>
</author-notes>
